Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Casirivimab/i..
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Sotrovimab
Vitamin A
Vitamin C
Vitamin D
Zinc

Other
Feedback Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Lactoferrin (meta)
Aspirin (meta) Melatonin (meta)
Bamlaniv../e.. (meta) Metformin (meta)
Bebtelovimab (meta) Molnupiravir (meta)
Bromhexine (meta) N-acetylcys.. (meta)
Budesonide (meta) Nigella Sativa (meta)
Cannabidiol (meta) Nitazoxanide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Mortality 45% Improvement Relative Risk Mortality (b) 40% Mortality (c) 35% Mortality (d) 26% Mortality (e) 20% Mortality (f) 12% Hospitalization 22% Hospitalization (b) 20% Hospitalization (c) 17% Hospitalization (d) 12% Hospitalization (e) 9% Hospitalization (f) 5% c19vitamind.com Seal et al. Vitamin D for COVID-19 Sufficiency Favors vitamin D Favors control
Seal, vitamin D sufficiency study: 45% lower mortality [p=0.001] and 22% lower hospitalization [p=0.01] https://c19p.org/seal
copied to clipboard
Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality
Seal et al., Journal of General Internal Medicine, doi:10.1007/s11606-021-07170-0
1 Jan 2022    Source   PDF   Share   Tweet
Retrospective 4,599 COVID+ veterans in the USA with vitamin D levels measured 15 to 90 days prior to testing positive, showing a significant independent inverse dose-response relationship between vitamin D levels (from 15 to 60ng/mL) and decreasing risk of hospitalization (24.1% to 18.7%, p = 0.009) and mortality (10.4% to 5.7%, p = 0.001).
risk of death, 45.1% lower, RR 0.55, p = 0.001, adjusted per study, 60ng/mL vs. 15 ng/mL.
risk of death, 40.5% lower, RR 0.60, p = 0.001, adjusted per study, 50ng/mL vs. 15 ng/mL.
risk of death, 34.6% lower, RR 0.65, p = 0.001, adjusted per study, 40ng/mL vs. 15 ng/mL.
risk of death, 25.9% lower, RR 0.74, p = 0.001, adjusted per study, 30ng/mL vs. 15 ng/mL.
risk of death, 20.0% lower, RR 0.80, p = 0.001, adjusted per study, 25ng/mL vs. 15 ng/mL.
risk of death, 11.5% lower, RR 0.88, p = 0.001, adjusted per study, 20ng/mL vs. 15 ng/mL.
risk of hospitalization, 22.5% lower, RR 0.78, p = 0.01, adjusted per study, 60ng/mL vs. 15 ng/mL.
risk of hospitalization, 20.0% lower, RR 0.80, p = 0.009, adjusted per study, 50ng/mL vs. 15 ng/mL.
risk of hospitalization, 16.7% lower, RR 0.83, p = 0.007, adjusted per study, 40ng/mL vs. 15 ng/mL.
risk of hospitalization, 12.3% lower, RR 0.88, p = 0.008, adjusted per study, 30ng/mL vs. 15 ng/mL.
risk of hospitalization, 9.1% lower, RR 0.91, p = 0.01, adjusted per study, 25ng/mL vs. 15 ng/mL.
risk of hospitalization, 4.8% lower, RR 0.95, p = 0.02, adjusted per study, 20ng/mL vs. 15 ng/mL.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Seal et al., 1/1/2022, retrospective, USA, North America, peer-reviewed, 6 authors.
All Studies   Meta Analysis
This PaperVitamin DAll
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit